CoreAge Rx vs Vitalex Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Vitalex Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 57 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Vitalex Health a bad call — it's best for people comparing flat-rate compounded care who confirm the actual supplied quantity, included services, state access and written cancellation deadline. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Vitalex Health |
|---|---|---|
| Brief Score | 94/100 (A) | 57/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Full program quote unconfirmed Compounded treatment; stated flat rate includes applicable pharmacy/clinical/platform portions, no consultation charge or dose-change surcharge. Exact amount, dose/supply and patient-state eligibility unconfirmed. FAQ 30-day versus terms 48-hour renewal notice. Initial order cancellation only within 24 hours before provider-network receipt; wrong/damaged claims within 48 hours. Return/disposal provisions require clarification. Full price detailsCompounded semaglutide weekly program offered; complete selected-program quote unknown; flat-rate offer states no consultation charge or dose-change surcharge, with bundled medication, clinical care and platform access |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Full program quote unconfirmed Compounded treatment; stated flat rate includes applicable pharmacy/clinical/platform portions, no consultation charge or dose-change surcharge. Exact amount, dose/supply and patient-state eligibility unconfirmed. FAQ 30-day versus terms 48-hour renewal notice. Initial order cancellation only within 24 hours before provider-network receipt; wrong/damaged claims within 48 hours. Return/disposal provisions require clarification. Full price detailsCompounded tirzepatide weekly program offered; complete selected-program quote unknown; flat-rate offer states no consultation charge or dose-change surcharge, with bundled medication, clinical care and platform access |
| Coverage | US only; restrictions by state, confirmed at intake | Pages advertise nationwide telehealth but terms restrict service to states where the network operates; no complete current patient-state list established |
| Brand-name access | Not confirmed | Current program descriptions are compounded; branded scientific comparisons do not establish a current branded prescribing offer. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Vitalex Health: Full quote unconfirmed, but consultation and dose-change surcharges are expressly excluded. Single bundled subscription price; FAQ 30-day notice differs from terms 48 hours. Initial order and delivery claims have separate deadlines.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.